Prostate-specific antigen velocity as a predictor of survival outcomes in patients with prostate cancer: a meta-analysis. [PDF]
Cui F +5 more
europepmc +1 more source
Additional predictive value of systemic inflammation indices beyond prostate specific antigen density for clinically significant prostate cancer. [PDF]
Sulhan H, Kalyenci B.
europepmc +1 more source
Abnormal Flagging of Prostate Specific Antigen Screening Tests: A Regression Discontinuity Design. [PDF]
Lewicki P +5 more
europepmc +1 more source
Postmortem Serum Prostate-Specific Antigen as a Potential Marker for Prostatic Disease: A Forensic Exploratory Study. [PDF]
Matsumoto S, Takasu S.
europepmc +1 more source
Impact of Cadmium on Prostate-Specific Antigen and Endothelial Markers: A Risk for Prostatic Damage. [PDF]
İritaş SB +8 more
europepmc +1 more source
Effect of apalutamide dosage on the incidence of cutaneous adverse events and prostate-specific antigen reduction in patients with prostate cancer. [PDF]
Matsuyama T +7 more
europepmc +1 more source
From prostate-specific antigen to precision: The future of prostate cancer diagnosis with artificial intelligence, biomarkers, and imaging. [PDF]
Flôres Soares da Silva HM +7 more
europepmc +1 more source
Web-Based Personalized Machine Learning Recommendations to Enhance Shared Decision-Making in Prostate-Specific Antigen Screening: Randomized Controlled Trial. [PDF]
Lin YT +4 more
europepmc +1 more source
Detectable prostate-specific antigen after radiotherapy for clinically localized prostate cancer. [PDF]
Falagario UG +18 more
europepmc +1 more source

